ONWARD® Medical Submits De Novo Application to FDA for its

ONWARD Medical has submitted its De Novo application to the US Food and Drug Administration (FDA) to allow marketing of its breakthrough ARC-EX System. ...

Related Keywords

Switzerland ,Canada ,Craig Hospital ,Colorado ,United States ,United Kingdom ,Boston ,Massachusetts ,Amsterdam ,Noord Holland ,Netherlands ,Engineering Center ,Swiss ,Aditi Roy ,Khaled Bahi ,Swiss Federal Institute Of Technology ,Neither The Company ,Drug Administration ,Youtube ,Vp Communications ,Lausanne University Hospital ,Linkedin ,World Health Organization Fact Sheet ,Candy Tefertiller ,Executive Director ,Device Designation ,Traumatic Spinal Injury ,Global Epidemiology ,Breakthrough Device Designations ,Swiss Federal Institute ,Euronext Brussels ,Media Enquiries ,Investor Enquiries ,